Dr Reddy’s And BMS Shake Hands On Pomalyst Settlement

Final Judgment Says Reddy’s Does Not Infringe Key Drug Substance Patent

 
• By Dean Rudge
  
Clock disintegrates, time running out concept
Time is ticking for BMS' major patent cliff • Source: Piotr Adamowicz / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business